Barbara Bispham

Insider Reports History

Location
Waltham, MA
Signature
/s/ Barbara Bispham
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Bispham:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRESCENT BIOPHARMA, INC. General Counsel and Corporate Secretary. Ordinary Shares 18,422 $277,803 $15.08 15 Dec 2025 Direct
CRESCENT BIOPHARMA, INC. General Counsel and Corporate Secretary. Stock Option (Right to Buy) 72,185 15 Dec 2025 Direct

Insider Reports Filed by Barbara Bispham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLYC CRESCENT BIOPHARMA, INC. 15 Dec 2025 3 $0 4 General Counsel and Corporate Secretary. 17 Dec 2025, 16:35
GLYC CRESCENT BIOPHARMA, INC. 13 Jun 2025 0 $0 3 General Counsel and Corporate Secretary. Exhibit 24 - Power of Attorney 30 Jun 2025, 16:16